| B.Ar/T.Ar% | Sb. Th | FD | Ip | ALP | MMP9 | OPG/RANKL | MANKIN |
---|
B.Ar/T.Ar%
| 1.000 | Â | Â | Â | Â | Â | Â | Â |
Sb. Th
| 0.381* | 1.000 | Â | Â | Â | Â | Â | Â |
FD
| -0.861** | -0.450* | 1.000 | Â | Â | Â | Â | Â |
Ip
| 0.963** | 0.347 | -0.868** | 1.000 | Â | Â | Â | Â |
ALP
| 0.814** | 0.453 | -0.754** | 0.718** | 1.000 | Â | Â | Â |
MMP9
| -0.115 | -0.195 | 0.262 | -0.094 | -0.311 | 1.000 | Â | Â |
OPG/RANKL
| -0.280 | -0.120 | 0.340 | -0.247 | -0.054 | 0.500* | 1.000 | Â |
MANKIN
| -0.627** | -0.626** | 0.672** | -0.598** | -0.788** | 0.460 | 0.341 | 1.000 |
- * Correlation is significant at the 0.05 level (2-tailed).
- ** Correlation is significant at the 0.001 level (2-tailed).
- The correlation coefficients represented in this table are obtained comparing the healthy, OA, OP and OPOA groups by Spearman bivariate analysis.
- B.Ar/T.Ar%, bone area fraction; FD, fractal dimension; Ip, polar moment of inertia; MANKIN, cartilage histopathological Mankin grading scorel; MMP9, metalloproteinase 9; OA, osteoarthritis; OP, osteoporosis; OPG/RANKL ratio, osteoprotegerin/receptor activator of nuclear factor-κB ratio; Sb.Th, subchondral plate thickness.